Literature DB >> 34152371

Association Between Race and COVID-19 Outcomes Among 2.6 Million Children in England.

Defne Saatci1, Tom A Ranger1, Cesar Garriga1, Ash Kieran Clift1,2, Francesco Zaccardi3, Pui San Tan1, Martina Patone1, Carol Coupland4, Anthony Harnden1, Simon J Griffin5,6, Kamlesh Khunti3, Hajira Dambha-Miller7, Julia Hippisley-Cox1.   

Abstract

Importance: Although children mainly experience mild COVID-19 disease, hospitalization rates are increasing, with limited understanding of underlying factors. There is an established association between race and severe COVID-19 outcomes in adults in England; however, whether a similar association exists in children is unclear. Objective: To investigate the association between race and childhood COVID-19 testing and hospital outcomes. Design, Setting, Participants: In this cohort study, children (0-18 years of age) from participating family practices in England were identified in the QResearch database between January 24 and November 30, 2020. The QResearch database has individually linked patients with national SARS-CoV-2 testing, hospital admission, and mortality data. Exposures: The main characteristic of interest is self-reported race. Other exposures were age, sex, deprivation level, geographic region, household size, and comorbidities (asthma; diabetes; and cardiac, neurologic, and hematologic conditions). Main Outcomes and Measures: The primary outcome was hospital admission with confirmed COVID-19. Secondary outcomes were SARS-CoV-2-positive test result and any hospital attendance with confirmed COVID-19 and intensive care admission.
Results: Of 2 576 353 children (mean [SD] age, 9.23 [5.24] years; 48.8% female), 410 726 (15.9%) were tested for SARS-CoV-2 and 26 322 (6.4%) tested positive. A total of 1853 children (0.07%) with confirmed COVID-19 attended hospital, 343 (0.01%) were admitted to the hospital, and 73 (0.002%) required intensive care. Testing varied across race. White children had the highest proportion of SARS-CoV-2 tests (223 701/1 311 041 [17.1%]), whereas Asian children (33 213/243 545 [13.6%]), Black children (7727/93 620 [8.3%]), and children of mixed or other races (18 971/147 529 [12.9%]) had lower proportions. Compared with White children, Asian children were more likely to have COVID-19 hospital admissions (adjusted odds ratio [OR], 1.62; 95% CI, 1.12-2.36), whereas Black children (adjusted OR, 1.44; 95% CI, 0.90-2.31) and children of mixed or other races (adjusted OR, 1.40; 95% CI, 0.93-2.10) had comparable hospital admissions. Asian children were more likely to be admitted to intensive care (adjusted OR, 2.11; 95% CI, 1.07-4.14), and Black children (adjusted OR, 2.31; 95% CI, 1.08-4.94) and children of mixed or other races (adjusted OR, 2.14; 95% CI, 1.25-3.65) had longer hospital admissions (≥36 hours). Conclusions and Relevance: In this large population-based study exploring the association between race and childhood COVID-19 testing and hospital outcomes, several race-specific disparities were observed in severe COVID-19 outcomes. However, ascertainment bias and residual confounding in this cohort study should be considered before drawing any further conclusions. Overall, findings of this study have important public health implications internationally.

Entities:  

Mesh:

Year:  2021        PMID: 34152371      PMCID: PMC8218232          DOI: 10.1001/jamapediatrics.2021.1685

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   26.796


  22 in total

1.  Association of Household Deprivation, Comorbidities, and COVID-19 Hospitalization in Children in Germany, January 2020 to July 2021.

Authors:  Nico Dragano; Olga Dortmann; Jörg Timm; Matthias Mohrmann; Rosemarie Wehner; Christoph J Rupprecht; Maria Scheider; Ertan Mayatepek; Morten Wahrendorf
Journal:  JAMA Netw Open       Date:  2022-10-03

2.  Factors Associated With COVID-19 Disease Severity in US Children and Adolescents.

Authors:  James W Antoon; Carlos G Grijalva; Cary Thurm; Troy Richardson; Alicen B Spaulding; Ronald J Teufel; Mario A Reyes; Samir S Shah; Julianne E Burns; Chén C Kenyon; Adam L Hersh; Derek J Williams
Journal:  J Hosp Med       Date:  2021-10       Impact factor: 2.899

Review 3.  Immunology of SARS-CoV-2 infection in children.

Authors:  Janet Chou; Paul G Thomas; Adrienne G Randolph
Journal:  Nat Immunol       Date:  2022-02-01       Impact factor: 31.250

4.  Impact of environmental and individual factors on COVID-19 mortality in children and adolescents in Mexico: An observational study.

Authors:  Carlos Sanchez-Piedra; Ana-Estela Gamiño-Arroyo; Copytzy Cruz-Cruz; Francisco-Javier Prado-Galbarro
Journal:  Lancet Reg Health Am       Date:  2022-01-20

5.  Comparison of the First and Second Waves of the Coronavirus Disease 2019 Pandemic in Children and Adolescents in a Middle-Income Country: Clinical Impact Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Gamma Lineage.

Authors:  Eduardo A Oliveira; Ana Cristina Simões E Silva; Maria Christina L Oliveira; Enrico A Colosimo; Robert H Mak; Mariana A Vasconcelos; Debora M Miranda; Daniella B Martelli; Ludmila R Silva; Clara C Pinhati; Hercílio Martelli-Júnior
Journal:  J Pediatr       Date:  2022-01-11       Impact factor: 6.314

6.  Vaccinating adolescents wisely against COVID-19.

Authors:  Maurizio Bonati; Eva Benelli
Journal:  BMJ Paediatr Open       Date:  2021-09-01

7.  Increase in the Number of Pediatric New-Onset Diabetes and Diabetic Ketoacidosis Cases During the COVID-19 Pandemic.

Authors:  Melissa A Chambers; Cherisse Mecham; Elsa Vazquez Arreola; Madhumita Sinha
Journal:  Endocr Pract       Date:  2022-02-18       Impact factor: 3.701

8.  Children, intersectionality, and COVID-19.

Authors:  Katy Dineen; Bengt Autzen; Nisreen A Alwan
Journal:  Lancet       Date:  2022-02-16       Impact factor: 79.321

Review 9.  SARS-CoV-2 Infection and Pancreatic β Cell Failure.

Authors:  Keiichiro Mine; Seiho Nagafuchi; Hitoe Mori; Hirokazu Takahashi; Keizo Anzai
Journal:  Biology (Basel)       Date:  2021-12-24

Review 10.  Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality.

Authors:  Jin-Jin Zhang; Xiang Dong; Guang-Hui Liu; Ya-Dong Gao
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-19       Impact factor: 10.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.